The countdown of the launch of the absolute winner in the obesity treatment market

The Ildong Pharmaceutical’s obesity treatment ‘Belviq (generic name: lorcaserin)‘, which recently acquired the sale approval from the Ministry of Food and Drug Safety, has attracted attention of the pharmaceutical market.

Since the sibutramine medicines were threw out from the market for the reason of the cardiovascular side effect on October 2010, the obesity treatment market has been an area...